© 2019 by sanguina, LLC.                        Terms of Use            Privacy Policy

ABOUT

Our multidisciplinary team is passionate about access to your health at your fingertips
 

Sanguina, LLC was founded to develop and commercialize our first product, AnemoCheck

AnemoCheck is a visual, color-based, rapid and disposable test for hemoglobin determination. The technology was developed within the biomedical engineering and pediatrics departments at the

Georgia Institute of Technology, Emory University, the Centers for Disease Control and Children's Healthcare of Atlanta. Our multidisciplinary team has developed AnemoCheck from the ground up. We have published initial clinical assessments, completed design and market analysis, received our first FDA clearance for clinical use and are now focused on commercialization of AnemoCheck. We are currently funded by the National Institutes of Health, the National Science Foundation, The Georgia Research Alliance, the Wallace H. Coulter Foundation and the Atlantic Pediatric Device Consortium. We continue to apply for grant funding, but are also seeking private investment. 

The sanguina team
Erika A. Tyburski
BS

Chief Executive Officer

Co-Founder

 

Erika has 6 years of key experience in development and business operations for Sanguina. She graduated in 2012 with her bachelor's degree in Biomedical Engineering and invented the AnemoCheck technology as an undergraduate at the Georgia Institute of Technology. She has driven clinical testing, regulatory efforts, design control processes and quality management systems for the company, leading to the company's first FDA-cleared product. She currently manages all company efforts and leads development of our over the counter technologies.

Wilbur A. Lam
MD, PhD

Chief Medical Officer

Co-Founder

 

Wilbur is a bioengineer and clinical pediatric hematologist/oncologist who is currently an Assistant Professor of Biomedical Engineering at Emory University and the Georgia Institute of Technology and the Department of Pediatrics, Division of Hematology/Oncology at Emory University School of Medicine.  Dr. Lam leads an interdisciplinary laboratory based at Georgia Tech and Emory dedicated to developing novel, inexpensive diagnostics for hematologic and childhood diseases. Wilbur serves as Chief Medical Officer at Sanguina, LLC and continues to supervise technical development of AnemoCheck.

Robert Mannino
PhD

Chief Technology Officer

 

Rob earned his PhD in biomedical engineering at the Georgia Institute of Technology and Emory University in 2018. Rob suffers from beta thalassemia major, a genetic blood disorder that causes him to be severely anemic and requires that he receive regular blood transfusions. His experience living with this disease motivates him to develop diagnostic technologies for anemia that can improve quality of life.  

Rob has extensive experience in computational analysis and leads development of our non-invasive technologies. 

René González

Chief Financial Officer

 

Rene is an entrepreneur with over 18 years of startup experience in numerous companies. During this time, he has played senior roles in finance, marketing, scaling operations, and business development.  Rene has been instrumental in establishing and scaling early-stage companies in various industries. Rene received both his undergraduate degree and MBA at MIT.  He has joined Sanguina as CFO focused on the financial model, funding and business development.

Tom S. Stribling
BS

Advisor

Co-Founder

 

Tom has over twenty-five years of experience in the health care industry, and companies he led have consistently reached successful and profitable liquidity through sale to larger corporations.  Prior to Sanguina, he started three other companies and joined three companies in turn-around situations.  All of these experiences were at the President and/or CEO level. 

Andrew L. Lyon
PhD

Chief Scientific Officer

Co-Founder

 

Andrew is currently Professor of Chemistry and Dean of the Schmid College of Science and Technology at Chapman University in Orange, CA and holds seven issued U.S. patents. Andrew has extensive experience in redox chemistry and dye-mediated electron transfer systems such as those utilized in AnemoCheck, which he is characterizing and optimizing. He currently serves as Chief Scientific Officer of Sanguina, LLC.